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which may be applied in the subcutaneous layers, was used. In May 1998 Baxter International, Inc (Deerfield, Ill) received approval from the US Food and Drug Administration for its new fibrin tissue sealant product. In 2001 the Tisseel Vapor Heated (VH) fibrin sealant, a sealant prepared from human plasma, became available for clinical use in the United States. According to the manufacturer, this sealant has been used in treating more than 6 million patients in Europe without any incidence of viral transmission. 5 Bioadhesives from the patients' own cryoprecipitateautologous fibrin glues-have been used effectively in surgery. 6 Although we have experience using such autologous fibrin glues, we chose the ready-to-use Tisseel tissue fibrin sealant because of its ease of use, relatively quick learning curve, and consistently reliable results.
The Tisseel Fibrin Sealant
The physiology of the fibrin glue mirrors that of the final common pathway of the normal coagulation cascade (Figure 1 ). Fibrinogen and thrombin develop a loose monomeric fibrin. The presence of factor XIII and calcium causes monomeric fibrin to form cross-links and become a polymeric fibrin, the "fibrin glue clot," which appears similar to a natural fibrin matrix when examined under an electron microscope (Figure 2 ). The normal degradation of this mesh is blocked by the addition of aprotinin, an antiprotease, thus prolonging its sealant action. 7 Preparing the Tisseel fibrin sealant required accuracy and attention to detail, but it was not difficult. The component fibrin sealant Tisseel contained the following substances in 4 separate vials: Component 1:
• Sealer protein concentrate (human fibrinogen), dried powder; fibrinolysis inhibitor solution (bovine aprotinin) Component 2:
• Thrombin (human) dried powder; calcium chloride solution Initially, the 2 vials making up component 1 were mixed. The 2 vials making up component 2 were mixed as well. Component 1 and component 2 solutions were delivered simultaneously with a special syringe, the Duploject syringe (Baxter AG, Vienna, Austria), in the form of a "mist" application. They combined to form the fibrin tissue sealant. The advantages of such a system include a singlehanded operation, thorough mixing of both components, and thin layer application. 8 Because it takes the fibrin sealant only 1 minute to activate and 3 minutes to solidify, speed in application was crucial. Approximately 3 mL of the fibrin sealant was needed to coat the neck surface area. 7 The goals of using the sealant were to:
• Eliminate dead space and avoid seromas/hematomas • Support the healing process by decreasing tension on the incision sites • Decrease edema • Promote hemostasis • Eliminate postoperative wrinkling or rippling of the skin There has been ample evidence with regard to the safety and efficacy of the Tisseel fibrin sealant. In clinical trials, Tisseel VH fibrin sealant controlled significantly more bleeding episodes (65%, 159/246) within 5 minutes than conventional topical agents including Avitene, Gelfoam, Oxyce, Surgicel, and Thrombinar (31%, 76/243; P = .0001). 9 Furthermore, fibrin sealant has been useful as an adjunct to hemostasis in surgery procedures involving cardiopulmonary bypass and treatment of splenic injuries caused by trauma and as an adjunct to closure of colostomies. 5,9,10 Depondt et al 11 demonstrated a decrease in hematoma rates when the Tisseel fibrin glue was used in parotidectomies. However, caution should be exercised before this product is used to treat patients who have potential allergies to cow products, such as bovine collagen. First, the patient underwent a standard neck recontouring with the suture suspension technique and lipoplasty as previously described. 4 The neck was infiltrated in a fashion similar to a rhytidectomy. A curvilinear submental incision was made, and the skin immediately overlying the platysma muscle in the midline was elevated with face lift scissors. Redundant fatty tissue overlying the platysma muscle was suctioned. The area of the submandibular tunnel was suctioned along its dermal surface to help encourage skin contracture and better definition of the mandibular border. Next, the platysma border in the midline was usually resected in a triangular fashion. Platysmal bands were either resected for approximately 2 to 3 cm on each side of the platysma border or sewn together. Two interlocking permanent sutures were placed at the depth desired to create a new cervicomental angle, one in a horizontal mattress fashion and the other in a vertical mattress fashion. The ends of the 2 sutures were removed from the submental incision and clamped separately. After that maneuver, an ellipse of redundant skin was excised behind the postauricular sulcus on each side. The skin was undermined to connect with the previously created submandibular tunnels. After the sutures were passed through the respective tunnels subcutaneously, the left mattress suture was tied to the right mastoid fascia, and the right interlocking mattress suture was tied to the left mastoid fascia. The sutures formed an artificial sling anchored to the mastoid bony fascia.
2 1 Use of Fibrin Sealant in Neck Contouring
After excellent hemostasis was achieved, the fibrin sealant was applied. On the side table, the fibrin sealant was prepared simultaneously, or reconstituted, in 2 separate syringes. One syringe contained the sealer protein concentrate dried powder mixed with the fibrinolysis inhibitor solution to make the Tisseel solution. The other syringe held the human thrombin, which was freeze dried and mixed with the calcium chloride solution to form the thrombin solution. Once the reconstitution has taken place, the Tisseel fibrin sealant must be used within 4 hours.
The dissected neck pockets were reinspected to ensure excellent hemostasis in the submental and postauricular regions. The instruments and gloves used were wet with saline solution to prevent the adherence to the sealant once it was applied. The 2 syringes were mounted on a Duploject applicator. The fibrin sealant was then sprayed 
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simultaneously into the pockets in thin layers for 60 seconds, the time required for the liquid sealant to activate. Gentle manual pressure was applied over the neck skin, with the surgeon's fingers spread evenly over the whole neck, to prevent pooling of the fibrin sealant in any given area. Such pooling may result in overlying skin necrosis, hematomas, seromas, or skin wrinkling caused by interruption of the vascular supply to the overlying dermis. This pressure was applied for 3 minutes, the time required for the fibrin sealant to solidify. Past potential complications of rippling or fluid collections were avoided because the skin flaps adhered immediately to the underlying tissues. The incisions were closed in a standard fashion. Paper tape was used to cover the neck, and dressings were placed (Figure 3 ).
Postoperative Care
Postoperative care was minimal. The dressings were removed after 24 hours, and the paper tape was removed after 48 hours with minimal ecchymosis and edema. Male patients were advised not to shave for a week to 10 days after operation to avoid trauma to the neck flaps.
Patients were instructed to resume activities of daily living in 2 to 3 days and strenuous activity, including exercise, in 3 to 4 weeks.
Results
Between January and July 2001, 60 patients, including 18 men and 42 women ranging in age from 33 to 70 years, underwent this technique (Figures 4 and 5 ). Some patients also had simultaneous procedures, such as chin augmentation, fat grafting, or blepharoplasties, as well as the suture suspension technique using fibrin sealant. No patients who underwent rhytidectomies were included in this study. The "recovery time,"-that is, the time necessary to return to activities of daily living and be cosmetically inconspicuous at work and at home-was reduced from 7 to 10 days to 2 to 3 days. There were no complications. The full recovery time was similar to that of the neck recontouring alone without the Tisseel fibrin sealant. Patients should be informed that it requires 6 months to allow for soft tissue contraction to reach its optimal state and for the fine edema resolution to be complete (Figures 6 and 7) .
Because of the fibrin sealant's ability to immediately seal raw surfaces and stop bleeding, since we began using it we have not had any occurrences of hematoma/seroma that required aspiration, and the amount of swelling has been markedly diminished. Furthermore, because postoperative bleeding is minimized by the sealant, the degree of ecchymosis experienced by patients treated with fibrin sealant has been significantly less than in those not treated with the sealant.
Discussion
Fibrin sealant in surgery has been used for decades in surgical procedures. Grey 12 A B surgery in 1915. Since then, fibrin glue has been widely used as a sealant in the various surgical specialties: In orthopedic surgery, it has been used for tendon repair and cartilage/bone grafting; in general surgery, for spleen and liver lacerations; in cardiovascular surgery, for vascular grafts and anastomoses; and in thoracic surgery, for sealing of seal thoracic duct leaks and esophageal anastomoses. 6 In plastic surgery, fibrin glue has been used for skin grafts and for nerve and microvascular repair.
There are few reports of the use of the fibrin sealant in cervicoplasty in the aesthetic surgical literature. Tisseel glue has been used before for procedures by Ellis and Pelausa, 6 who reported on 32 mostly aesthetic surgeries in 23 patients. They evaluated the outcome on the basis of the effectiveness of the glue. They reported "good" results in 81%, poor results in 12.5%, and ineffective use of the glue in 6.5%. Among the patients in our series, there was a noticeable improvement in recovery time, amount of edema and ecchymosis, and a quicker return to work. The clinical experience was so compelling and obvious in favor of the neck suspension technique with the Tisseel fibrin sealant that we believe a comparison study is unnecessary.
Conclusion
The safety profile, ease of administration, and consistently good results obtained with Tisseel fibrin sealant make it an excellent adjuvant to any neck lift procedure, especially the suture suspension technique described in this study. Its use has decreased hematoma/seroma rates, minimized the need for neck dressings in patients, and shortened the recovery time in patients undergoing neck recontouring with the suture suspension technique. 
